Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LAM RESEARCH CORP Director's Dealing 2025

Feb 6, 2025

29803_dirs_2025-02-06_d37e6a80-36f6-4adc-aa17-712560c1450f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LAM RESEARCH CORP (LRCX)
CIK: 0000707549
Period of Report: 2025-02-04

Reporting Person: Varadarajan Seshasayee (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-04 Common Stock M 14542 Acquired 179084 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-04 Market-based Performance Restricted Stock Unit $0 M 25540 Disposed Common Stock (25540) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2366.994 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Market-based Performance Restricted Stock Unit $0 Common Stock (29190) 29190 Direct
Market-based Performance Restricted Stock Unit $0 Common Stock (35950) 35950 Direct
Employee Stock Option (Right to Buy) $59.881 2028-03-01 Common Stock (12270) 12270 Direct
Employee Stock Option (Right to Buy) $30.033 2027-03-02 Common Stock (27480) 27480 Direct
Employee Stock Option (Right to Buy) $98.153 2031-03-01 Common Stock (23880) 23880 Direct
Employee Stock Option (Right to Buy) $17.675 2026-03-01 Common Stock (74320) 74320 Direct
Employee Stock Option (Right to Buy) $54.057 2029-03-01 Common Stock (20880) 20880 Direct
Employee Stock Option (Right to Buy) $49.092 2030-03-01 Common Stock (29400) 29400 Direct
Employee Stock Option (Right to Buy) $19.007 2025-03-01 Common Stock (35760) 35760 Direct

Footnotes

F1: On 03/01/2022, the Reporting Person received a target grant of 25,540 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 03/01/2025. The vesting of this award is based on the total return stock price performance of Lam Research shares (assuming reinvestment of dividends) relative to the market price performance of the PHLX Semiconductor Sector Total Return Index, comparing the 50-trading day trailing average closing price over the performance period from 02/01/2022 through 01/31/2025.

F2: The amount reported includes shares subject to unvested restricted stock units.

F3: The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2025. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2022 through 01/31/2025.

F4: The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2027. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2024 through 01/31/2027.

F5: The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2026. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2023 through 01/31/2026.

F6: The stock options will become exercisable in three equal installments on 03/01/2022, 03/01/2023, and 03/01/2024

F7: The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023.

F8: The stock options will become exercisable in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027.

F9: The stock options will become exercisable in three equal installments on 03/01/2020, 03/01/2021, and 03/01/2022.

F10: The stock options will become exercisable in three equal installments on 03/01/2023, 03/01/2024, and 03/01/2025

F11: The stock options will become exercisable in three equal installments on 03/01/2024, 03/01/2025, and 03/01/2026

F12: The stock options will become exercisable in three equal installments on 03/01/2019, 03/01/2020, and 03/01/2021.